Analysis of 1,25-Dihydroxyvitamin D3 Receptors (VDR. In Basal Cell Carcinomas

American Journal of Pathology - United States
doi 10.1016/s0002-9440(10)65153-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Points: 1,25 Dihydroxyvitamin D3 in Psoriasis

BMJ
1986English

Defective Binding and Function of 1,25-Dihydroxyvitamin D3 Receptors in Peripheral Mononuclear Cells of Patients With End-Organ Resistance to 1,25-Dihydroxyvitamin D.

Journal of Clinical Investigation
Medicine
1985English

Assessment of the Free Binding Energy of 1,25-Dihydroxyvitamin D3 and Its Analogs With the Human VDR Receptor Model.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2012English

Synergistic Effect of 1,25-Dihydroxyvitamin D3 and Retinoic Acid in Inducing U937 Cell Differentiation.

Journal of Nutritional Science and Vitaminology
MedicineNutritionDietetics
1992English

1,25 Dihydroxyvitamin D (1,25d) Lymphocyte Receptors Reflect Chances in VDR Target Tissues Induced by Phenorbarbital (Pb) in Rats

Pediatric Research
Child HealthPediatricsPerinatology
1992English

Prevention of Autoimmune Diabetes in NOD Mice by 1,25 Dihydroxyvitamin D3

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1994English

Induction of Monocytic Differentiation and Bone Resorption by 1,25-Dihydroxyvitamin D3.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1983English

Regulatory Effects of 1,25-Dihydroxyvitamin D3 on Vascular Smooth Muscle Cells.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2012English

SC-19220, a Prostaglandin E2 Antagonist, Inhibits Osteoclast Formation by 1,25-Dihydroxyvitamin D3 in Cell Cultures

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy